Related Experiment Video

Updated: Mar 31, 2026

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

15.7K

PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53

Thomas Grellety1,2,3, Audrey Laroche-Clary4,5, Vanessa Chaire6

  • 1National Institute of Health and Medical research, INSERM U916, Institut Bergonié, Bordeaux, France. t.grellety@bordeaux.unicancer.fr.

BMC Cancer
|October 15, 2015
PubMed
Abstract

Insights

PRIMA-1(MET) shows anti-tumor effects in soft-tissue sarcoma (STS) cells, but not solely via TP53 targeting. Its efficacy involves reactive oxygen species (ROS) toxicity, suggesting off-target mechanisms warranting further investigation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Soft-tissue sarcoma (STS) presents therapeutic challenges.
  • Targeting the TP53 pathway is a strategy for cancer treatment.
  • PRIMA-1(MET) has been investigated as a potential TP53-targeted therapy.

Purpose of the Study:

  • To evaluate the efficacy of PRIMA-1(MET) in soft-tissue sarcoma (STS) cells.
  • To elucidate the mechanisms of action of PRIMA-1(MET) in STS.
  • To determine if PRIMA-1(MET) acts as a TP53-targeted therapy in STS.

Main Methods:

  • Investigated PRIMA-1(MET) effects on apoptosis, cell cycle, oxidative stress, and autophagy.
  • Utilized a panel of 6 STS cell lines with varying TP53 mutational status.
  • Assessed cell viability reduction and mechanisms of cell death induction.

Main Results:

  • PRIMA-1(MET) reduced viability in 5 out of 6 STS cell lines.
  • Cell death was induced independently of TP53 status (mutated or null).
  • Reactive oxygen species (ROS) were crucial for PRIMA-1(MET) toxicity, leading to caspase-independent cell death.

Conclusions:

  • PRIMA-1(MET) exhibits anti-tumor activity in STS partly through off-target ROS toxicity.
  • PRIMA-1(MET) does not appear to be a solely TP53-targeted therapy in STS.
  • Further development of PRIMA-1(MET) as a TP53-targeted therapy for STS is not recommended based on these findings.

More Related Videos

Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells10:33

Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells

Published on: June 16, 2019

30.0K
Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

328

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.9K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K